OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease
Aliza Hussain, David J. Ramsey, Michelle Lee, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 8, pp. 933-942
Open Access | Times Cited: 16
Aliza Hussain, David J. Ramsey, Michelle Lee, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 8, pp. 933-942
Open Access | Times Cited: 16
Showing 16 citing articles:
Prescribing patterns of SGLT-2 inhibitors and their association with heart failure readmissions: a single-center cross-sectional study from a low- and middle-income country
Abrar Ali Chhachhar, Saadia Sattar, Farhala Baloch, et al.
Hospital Practice (2025) Vol. 53, Iss. 1
Closed Access
Abrar Ali Chhachhar, Saadia Sattar, Farhala Baloch, et al.
Hospital Practice (2025) Vol. 53, Iss. 1
Closed Access
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure
Mehmet Birhan Yılmaz, Ahmet Çelik, Anıl Şahin, et al.
Journal of the American Heart Association (2025)
Open Access
Mehmet Birhan Yılmaz, Ahmet Çelik, Anıl Şahin, et al.
Journal of the American Heart Association (2025)
Open Access
Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
Dapagliflozin versus empagliflozin in patients with chronic kidney disease
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 7
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 7
2023 Update in ambulatory general internal medicine
Jason T. Alexander, Simran Singh, Sachin Shah, et al.
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 1, pp. 40-46
Open Access | Times Cited: 2
Jason T. Alexander, Simran Singh, Sachin Shah, et al.
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 1, pp. 40-46
Open Access | Times Cited: 2
Overcoming Barriers to Use of SGLT2 Inhibitor Therapy
Stephen J. Greene, Jacob B. Pierce
JACC Heart Failure (2023) Vol. 11, Iss. 8, pp. 943-945
Closed Access | Times Cited: 4
Stephen J. Greene, Jacob B. Pierce
JACC Heart Failure (2023) Vol. 11, Iss. 8, pp. 943-945
Closed Access | Times Cited: 4
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity
Krunal Amin, Garrett Bethel, Larry R. Jackson, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 1113-1127
Closed Access | Times Cited: 4
Krunal Amin, Garrett Bethel, Larry R. Jackson, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 1113-1127
Closed Access | Times Cited: 4
Uptake of sodium-glucose cotransporter-2 inhibitors in hospitalized patients with heart failure: insights from the veterans affairs healthcare system
Anubodh S. Varshney, Jamie Calma, Neil Kalwani, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 1
Anubodh S. Varshney, Jamie Calma, Neil Kalwani, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 1
Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021
Taufiq Salahuddin, Annika Hebbe, Marguerite Daus, et al.
American Heart Journal (2023) Vol. 268, pp. 68-79
Closed Access | Times Cited: 2
Taufiq Salahuddin, Annika Hebbe, Marguerite Daus, et al.
American Heart Journal (2023) Vol. 268, pp. 68-79
Closed Access | Times Cited: 2
Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysis
Hamidreza Soleimani, Behrad Saeedian, Yeganeh Pasebani, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 2, pp. 637-648
Open Access | Times Cited: 2
Hamidreza Soleimani, Behrad Saeedian, Yeganeh Pasebani, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 2, pp. 637-648
Open Access | Times Cited: 2
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
Muhammad Sameer Arshad, Adeena Jamil, Stephen J. Greene, et al.
Heart Failure Reviews (2024)
Closed Access
Muhammad Sameer Arshad, Adeena Jamil, Stephen J. Greene, et al.
Heart Failure Reviews (2024)
Closed Access
Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally-Qualified Health Centers: A Thematic Qualitative Analysis
Sarah Philbin, Lacey P. Gleason, Stephen D. Persell, et al.
(2024)
Closed Access
Sarah Philbin, Lacey P. Gleason, Stephen D. Persell, et al.
(2024)
Closed Access
Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study
Justin C. Chen, Colette DeJong, Mansi Agarwal, et al.
Circulation Cardiovascular Quality and Outcomes (2024) Vol. 17, Iss. 11
Closed Access
Justin C. Chen, Colette DeJong, Mansi Agarwal, et al.
Circulation Cardiovascular Quality and Outcomes (2024) Vol. 17, Iss. 11
Closed Access
Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes
Hsuan-Yu Su, Chen‐Yi Yang, Yu‐Hsuan Lee, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2441765-e2441765
Open Access
Hsuan-Yu Su, Chen‐Yi Yang, Yu‐Hsuan Lee, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2441765-e2441765
Open Access
Implementation of sodium–glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be
Jacob B. Pierce, Javed Butler, Stephen J. Greene
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1659-1662
Closed Access | Times Cited: 1
Jacob B. Pierce, Javed Butler, Stephen J. Greene
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1659-1662
Closed Access | Times Cited: 1
